The adequacy of myocardial revascularization in patients with multivessel coronary artery disease.

[1]  M. Valgimigli,et al.  Five-year outcomes of surgical or percutaneous myocardial revascularization in diabetic patients. , 2013, International journal of cardiology.

[2]  J. Beckman,et al.  Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I , 2013, European heart journal.

[3]  J. Garot,et al.  Primary percutaneous coronary intervention in patients with acute myocardial infarction, resuscitated cardiac arrest, and cardiogenic shock: the role of primary multivessel revascularization. , 2013, JACC. Cardiovascular interventions.

[4]  Samin K. Sharma,et al.  Staged Versus One-time Complete Revascularization With Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease Patients Without ST-Elevation Myocardial Infarction , 2013, Circulation. Cardiovascular interventions.

[5]  Harlan M Krumholz,et al.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Circulation.

[6]  Jane A. Linderbaum,et al.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[7]  Jane A. Linderbaum,et al.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[8]  Michail I. Papafaklis,et al.  The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial. , 2013, Journal of the American College of Cardiology.

[9]  Akshay S. Desai,et al.  Strategies for multivessel revascularization in patients with diabetes. , 2012, The New England journal of medicine.

[10]  P. Pibarot,et al.  The impact of complete revascularization on long-term survival is strongly dependent on age. , 2012, The Annals of thoracic surgery.

[11]  D. Atar,et al.  ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation , 2013 .

[12]  Michael J Pencina,et al.  Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. , 2012, JAMA.

[13]  Nikola Jagic,et al.  Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. , 2012, The New England journal of medicine.

[14]  Y. Song,et al.  Complete versus incomplete revascularization for treatment of multivessel coronary artery disease in the drug-eluting stent era , 2012, Heart and Vessels.

[15]  B. Gersh,et al.  Complete versus incomplete revascularization with coronary artery bypass graft or percutaneous intervention in stable coronary artery disease. , 2012, Circulation. Cardiovascular interventions.

[16]  K. Park,et al.  Benefit of complete revascularization in patients with multivessel coronary disease in the drug-eluting stent era. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[17]  P. Serruys,et al.  Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score. , 2012, Journal of the American College of Cardiology.

[18]  B. Gersh,et al.  Impact of the Presence and Extent of Incomplete Angiographic Revascularization After Percutaneous Coronary Intervention in Acute Coronary Syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Trial , 2012, Circulation.

[19]  B. Bruyne.  Multivessel Disease From Reasonably Incomplete to Functionally Complete Revascularization , 2012 .

[20]  R. de Caterina,et al.  Isolated troponin increase after percutaneous coronary interventions: does it have prognostic relevance? , 2012, Atherosclerosis.

[21]  M. Bertolet,et al.  Impact of Completeness of Revascularization on Long-Term Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus: Results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) , 2012, Circulation. Cardiovascular interventions.

[22]  Mario J. Garcia,et al.  ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, Am , 2012, The Journal of thoracic and cardiovascular surgery.

[23]  G. Stone,et al.  Prognostic factors in primary and elective percutaneous coronary intervention , 2011 .

[24]  M. Mack,et al.  Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[25]  J. Spertus,et al.  ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, Am , 2012, Journal of the American College of Cardiology.

[26]  I. Édes,et al.  Various clinical scenarios leading to development of the string sign of the internal thoracic artery after coronary bypass surgery: the role of competitive flow, a case series , 2012, Journal of Cardiothoracic Surgery.

[27]  Laura Mauri,et al.  2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. , 2011, Circulation.

[28]  Min Chul Kim,et al.  What is optimal revascularization strategy in patients with multivessel coronary artery disease in non-ST-elevation myocardial infarction? Multivessel or culprit-only revascularization. , 2011, International journal of cardiology.

[29]  M. Mack,et al.  Bypass versus drug-eluting stents at three years in SYNTAX patients with diabetes mellitus or metabolic syndrome. , 2011, The Annals of thoracic surgery.

[30]  U. Siebert,et al.  Fractional flow reserve in unstable angina and non-ST-segment elevation myocardial infarction experience from the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) study. , 2011, JACC. Cardiovascular interventions.

[31]  M. Roffi,et al.  Current concepts on coronary revascularization in diabetic patients. , 2011, European heart journal.

[32]  Samin K. Sharma,et al.  Impact of Incomplete Revascularization on Long-Term Mortality After Coronary Stenting , 2011, Circulation. Cardiovascular interventions.

[33]  B. Gersh,et al.  Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. , 2011, Journal of the American College of Cardiology.

[34]  D. Holmes,et al.  Clinical ResearchInterventional CardiologyCulprit Vessel Only Versus Multivessel and Staged Percutaneous Coronary Intervention for Multivessel Disease in Patients Presenting With ST-Segment Elevation Myocardial Infarction: A Pairwise and Network Meta-Analysis , 2011 .

[35]  Kevin Kennedy,et al.  Appropriateness of percutaneous coronary intervention. , 2011, JAMA.

[36]  D. Berman,et al.  Myocardial viability and survival in ischemic left ventricular dysfunction. , 2011, The New England journal of medicine.

[37]  Uwe Siebert,et al.  Economic Evaluation of Fractional Flow Reserve–Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease , 2010, Circulation.

[38]  William Wijns,et al.  Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction. , 2010, JACC. Cardiovascular interventions.

[39]  P. Serruys,et al.  Impact of completeness of revascularization on the five-year outcome in percutaneous coronary intervention and coronary artery bypass graft patients (from the ARTS-II study). , 2010, The American journal of cardiology.

[40]  H. Krumholz,et al.  Putting ad hoc PCI on pause. , 2010, JAMA.

[41]  G. Sangiorgi,et al.  Mehran Contrast-Induced Nephropathy Risk Score Predicts Short- and Long-Term Clinical Outcomes in Patients With ST-Elevation–Myocardial Infarction , 2010, Circulation. Cardiovascular interventions.

[42]  Volkmar Falk,et al.  Guidelines on Myocardial Revascularization the Task Force on Myocardial Revascularization of the European Society of Cardiology (esc) and the European Association for Cardio-thoracic Surgery (eacts) Developed with the Special Contribution of the European Association for Percutaneous Cardiovascular I , 2022 .

[43]  Uwe Siebert,et al.  Clinical ResearchInterventional CardiologyFractional Flow Reserve Versus Angiography for Guiding Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease: 2-Year Follow-Up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Study , 2010 .

[44]  L. Wallentin,et al.  Relation between renal function, presentation, use of therapies and in‐hospital complications in acute coronary syndrome: data from the SWEDEHEART register , 2010, Journal of internal medicine.

[45]  N. Curzen,et al.  Coronary revascularisation in chronic kidney disease. Part II: acute coronary syndromes. , 2010, Journal of renal care.

[46]  N. Curzen,et al.  Coronary revascularisation in chronic kidney disease. Part 1: stable coronary artery disease. , 2010, Journal of renal care.

[47]  P. Serruys,et al.  Complete percutaneous revascularization for multivessel disease in patients with impaired left ventricular function: pre- and post-procedural evaluation by cardiac magnetic resonance imaging. , 2010, JACC. Cardiovascular interventions.

[48]  W. Wijns,et al.  Fractional flow reserve and myocardial perfusion imaging in patients with angiographic multivessel coronary artery disease. , 2010, JACC. Cardiovascular interventions.

[49]  U. Siebert,et al.  Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. , 2009, The New England journal of medicine.

[50]  I. Ford,et al.  Validation of Magnetic Resonance Myocardial Perfusion Imaging With Fractional Flow Reserve for the Detection of Significant Coronary Heart Disease , 2009, Circulation.

[51]  J. Ornato,et al.  2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST‐Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update) , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[52]  G. Sangiorgi,et al.  A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up , 2009, Heart.

[53]  F. Mohr,et al.  Does Reasonable Incomplete Surgical Revascularization Affect Early or Long-Term Survival in Patients With Multivessel Coronary Artery Disease Receiving Left Internal Mammary Artery Bypass to Left Anterior Descending Artery? , 2009, Circulation.

[54]  L. Wallentin,et al.  Influence of Renal Function on the Effects of Early Revascularization in Non–ST-Elevation Myocardial Infarction: Data From the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) , 2009, Circulation.

[55]  P. Kolh,et al.  Appropriate myocardial revascularization: a joint viewpoint from an interventional cardiologist and a cardiac surgeon. , 2009, European heart journal.

[56]  Sunil V. Rao,et al.  Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry). , 2009, The American journal of cardiology.

[57]  E. Paolasso,et al.  Culprit-only or multivessel percutaneous coronary stenting in patients with non-ST-segment elevation acute coronary syndromes: one-year follow-up. , 2009, Journal of interventional cardiology.

[58]  Ying-xin Zhao,et al.  Comparison of drug-eluting stents and coronary artery bypass grafting for the treatment of multivessel coronary artery disease in patients with chronic kidney disease. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[59]  Maria Mori Brooks,et al.  A randomized trial of therapies for type 2 diabetes and coronary artery disease. , 2009, The New England journal of medicine.

[60]  Christopher M O'Connor,et al.  Coronary bypass surgery with or without surgical ventricular reconstruction. , 2009, The New England journal of medicine.

[61]  S. Pocock,et al.  Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials , 2009, The Lancet.

[62]  Alice Jacobs,et al.  Predictors and outcomes of ad hoc versus non-ad hoc percutaneous coronary interventions. , 2009, JACC. Cardiovascular interventions.

[63]  Grace A Lin,et al.  Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention. , 2008, JAMA.

[64]  K. Dimopoulos,et al.  Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug‐eluting stents , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[65]  Guido Germano,et al.  Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy , 2008, Circulation.

[66]  R. Higgins,et al.  Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. , 2008, The New England journal of medicine.

[67]  O. Penn,et al.  Does stenosis severity of native vessels influence bypass graft patency? A prospective fractional flow reserve-guided study. , 2007, The Annals of thoracic surgery.

[68]  Bari Investigators.  The final 10-year follow-up results from the BARI randomized trial. , 2007 .

[69]  D. Berman,et al.  Optimal medical therapy with or without PCI for stable coronary disease. , 2007, The New England journal of medicine.

[70]  Deepak L. Bhatt,et al.  In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting? , 2007, Journal of the American College of Cardiology.

[71]  Robert M. Minutello,et al.  Outcomes following immediate (ad hoc) versus staged percutaneous coronary interventions (report from the 2000 to 2001 New York State Angioplasty Registry). , 2007, The American journal of cardiology.

[72]  P. Serruys,et al.  Complete Revascularization: Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention , 2006, Circulation.

[73]  R. de Caterina,et al.  Rapid decline of collateral circulation increases susceptibility to myocardial ischemia: the trade-off of successful percutaneous recanalization of chronic total occlusions. , 2006, Journal of the American College of Cardiology.

[74]  Samin K. Sharma,et al.  Impact of Completeness of Percutaneous Coronary Intervention Revascularization on Long-Term Outcomes in the Stent Era , 2006, Circulation.

[75]  Wen Cheng,et al.  In the current era, complete revascularization improves survival after coronary artery bypass surgery. , 2005, The Journal of thoracic and cardiovascular surgery.

[76]  B. McNeil,et al.  "Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. , 2004, Journal of the American Society of Nephrology : JASN.

[77]  J. Beckman,et al.  Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I , 2013, European heart journal.

[78]  G. Beller,et al.  Incremental value of combined perfusion and function over perfusion alone by gated SPECT myocardial perfusion imaging for detection of severe three-vessel coronary artery disease. , 2003, Journal of the American College of Cardiology.

[79]  A. Collins,et al.  Comparative Survival of Dialysis Patients in the United States After Coronary Angioplasty, Coronary Artery Stenting, and Coronary Artery Bypass Surgery and Impact of Diabetes , 2002, Circulation.

[80]  M. Ward,et al.  Exaggeration of nonculprit stenosis severity during acute myocardial infarction: implications for immediate multivessel revascularization. , 2002, Journal of the American College of Cardiology.

[81]  L. Shaw,et al.  Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. , 2002, Journal of the American College of Cardiology.

[82]  H. Schaff,et al.  What constitutes optimal surgical revascularization? Answers from the Bypass Angioplasty Revascularization Investigation (BARI). , 2002, Journal of the American College of Cardiology.

[83]  P. Serruys,et al.  The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. , 2002, Journal of the American College of Cardiology.

[84]  T. Bowker,et al.  Difference in the mortality of the CABRI diabetic and nondiabetic populations and its relation to coronary artery disease and the revascularization mode. , 2001, The American journal of cardiology.

[85]  M. Gotsman,et al.  Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus: a clue to the explanation of the results of the BARI study. Balloon Angioplasty Revascularization Investigation. , 1997, Journal of the American College of Cardiology.

[86]  Robert L. Frye,et al.  Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. , 1996, The New England journal of medicine.

[87]  P. H. van der Voort,et al.  Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. , 1996, The New England journal of medicine.

[88]  Z. Bloomgarden,et al.  Potential mechanisms promoting restenosis in diabetic patients. , 1996, Journal of the American College of Cardiology.

[89]  B. Gersh,et al.  Effect of Completeness of Revascularization on Long‐term Outcome of Patients With Three‐Vessel Disease Undergoing Coronary Artery Bypass Surgery: A Report From the Coronary Artery Surgery Study (CASS) Registry , 1992, Circulation.

[90]  B. Brent,et al.  Coronary artery bypass surgery in patients with left ventricular dysfunction. , 1986, The American journal of medicine.

[91]  C. Berry,et al.  Usefulness of fractional flow reserve to improve diagnostic efficiency in patients with non-ST elevation myocardial infarction. , 2013, The American journal of cardiology.

[92]  Deepak L. Bhatt,et al.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Circulation.

[93]  K. Mahaffey,et al.  Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology ( ESC ) , 2012 .

[94]  S. Rajpathak,et al.  Clinical outcomes based on completeness of revascularisation in patients undergoing percutaneous coronary intervention: a meta-analysis of multivessel coronary artery disease studies. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[95]  Takeshi Kimura,et al.  Predicting Long-Term Mortality After First Coronary Revascularization , 2012 .

[96]  B. Gersh.  Impact of Angiographic Complete Revascularization After Drug-Eluting Stent Implantation or Coronary Artery Bypass Graft Surgery for Multivessel Coronary Artery Disease , 2012 .

[97]  B. Gersh,et al.  Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation , 2011 .

[98]  Samin K. Sharma,et al.  Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. , 2010, JACC. Cardiovascular interventions.

[99]  Samin K. Sharma,et al.  Incomplete revascularization in the era of drug-eluting stents: impact on adverse outcomes. , 2009, JACC. Cardiovascular interventions.

[100]  R. de Caterina,et al.  Complete myocardial revascularization: between myth and reality. , 2005, European heart journal.

[101]  J. Parrillo,et al.  How well does radionuclide dipyridamole stress testing detect three-vessel coronary artery disease and ischemia in the region supplied by the most stenotic vessel? , 1999, Clinical nuclear medicine.